Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 May 11;11(5):717.
doi: 10.3390/biom11050717.

Regulation of Tissue Inflammation by 12-Lipoxygenases

Affiliations
Review

Regulation of Tissue Inflammation by 12-Lipoxygenases

Abhishek Kulkarni et al. Biomolecules. .

Abstract

Lipoxygenases (LOXs) are lipid metabolizing enzymes that catalyze the di-oxygenation of polyunsaturated fatty acids to generate active eicosanoid products. 12-lipoxygenases (12-LOXs) primarily oxygenate the 12th carbon of its substrates. Many studies have demonstrated that 12-LOXs and their eicosanoid metabolite 12-hydroxyeicosatetraenoate (12-HETE), have significant pathological implications in inflammatory diseases. Increased level of 12-LOX activity promotes stress (both oxidative and endoplasmic reticulum)-mediated inflammation, leading to damage in these tissues. 12-LOXs are also associated with enhanced cellular migration of immune cells-a characteristic of several metabolic and autoimmune disorders. Genetic depletion or pharmacological inhibition of the enzyme in animal models of various diseases has shown to be protective against disease development and/or progression in animal models in the setting of diabetes, pulmonary, cardiovascular, and metabolic disease, suggesting a translational potential of targeting the enzyme for the treatment of several disorders. In this article, we review the role of 12-LOXs in the pathogenesis of several diseases in which chronic inflammation plays an underlying role.

Keywords: 12-LOXs; 12-lipoxygenases; 12/15-LOX; 12/15-lipoxygenase; eicosanoids; inflammation; lipoxygenases.

PubMed Disclaimer

Conflict of interest statement

J.L.N. and R.G.M. serve on the Scientific Advisory Board of Veralox Therapeutics.

Figures

Figure 1
Figure 1
Substrates and products of the 12-lipoxygenases.
Figure 2
Figure 2
Lipoxygenase orthologs.
Figure 3
Figure 3
The 12-Lipoxygenase Pathway.
Figure 4
Figure 4
12-Lipoxygenases play a role in a variety of inflammatory pathways and present a potential target for several inflammatory conditions.

References

    1. A current view on inflammation. Nat. Immunol. 2017;18:825. doi: 10.1038/ni.3798. - DOI - PubMed
    1. Furman D., Campisi J., Verdin E., Carrera-Bastos P., Targ S., Franceschi C., Ferrucci L., Gilroy D.W., Fasano A., Miller G.W., et al. Chronic inflammation in the etiology of disease across the life span. Nat. Med. 2019;25:1822–1832. doi: 10.1038/s41591-019-0675-0. - DOI - PMC - PubMed
    1. Imig J.D., Hye Khan M.A. Cytochrome P450 and lipoxygenase metabolites on renal function. Compr. Physiol. 2015;6:423–441. doi: 10.1002/cphy.c150009. - DOI - PMC - PubMed
    1. Piomelli D. Arachidonic acid in cell signaling. Curr. Opin. Cell Biol. 1993;5:274–280. doi: 10.1016/0955-0674(93)90116-8. - DOI - PubMed
    1. Ikei K.N., Yeung J., Apopa P.L., Ceja J., Vesci J., Holman T.R., Holinstat M. Investigations of human platelet-type 12-lipoxygenase: Role of lipoxygenase products in platelet activation. J. Lipid Res. 2012;53:2546–2559. doi: 10.1194/jlr.M026385. - DOI - PMC - PubMed

Publication types

Substances